Lexeo Therapeutics, Inc. · NASDAQ:LXEO
JPMorgan Chase & Co reported a 5.50% stake in Lexeo Therapeutics, Inc. (Schedule 13G)
Event Sep 30, 2026 · Filed Oct 13, 2026
JPMorgan Chase & Co reported a 5.50% stake in Lexeo Therapeutics, Inc., 4,573,701 shares, as a passive investor on Sep 30, 2026. Filed Oct 13, 2026 (Schedule 13G).
- Stake
- 5.50%
- Shares
- 4,573,701
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JPMORGAN CHASE & CO. | 5.50% | 4,573,701 |